PLK1 and neoplasm: Further research also showed that high PLK1 expression was related to shorter metastasis-free survival and poor response to endocrine therapy in hormone-receptor-positive breast cancer, whereas PLK1 inhibition resulted in tumor shrinkage and acquired palbociclib resistance (Montaudon et al., 2020).